Overview

Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease

Status:
Completed
Trial end date:
2016-07-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness of symptom control in gastroesophageal reflux disease (GERD) participants following treatment with dexlansoprazole.
Phase:
Phase 4
Details
Lead Sponsor:
Takeda
Treatments:
Dexlansoprazole
Lansoprazole